Europe Drug Testing Market By Drug Type (Cannabis/Marijuana, Opioids, Cocaine, Alcohol, Amphetamine & Methamphetamine, LSD and Others), By Sample Type (Urine Samples, Oral Fluid Samples, Hair Samples and Other Samples), By Product Type (Consumables, Instruments, Rapid Testing Devices and Services), By End User (Drug Testing Laboratories, Workplaces, Hospitals and Others), By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Drug Testing Market, by Drug Type
1.4.2 Europe Drug Testing Market, by Sample Type
1.4.3 Europe Drug Testing Market, by Product Type
1.4.4 Europe Drug Testing Market, by End User
1.4.5 Europe Drug Testing Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Drug Testing Market by Drug Type
3.1 Europe Cannabis/Marijuana Drug Testing Market by Country
3.2 Europe Opioids Drug Testing Market by Country
3.3 Europe Cocaine Drug Testing Market by Country
3.4 Europe Alcohol Drug Testing Market by Country
3.5 Europe Amphetamine & Methamphetamine Drug Testing Market by Country
3.6 Europe LSD Drug Testing Market by Country
3.7 Europe Other Drug Type Drug Testing Market by Country

Chapter 4. Europe Drug Testing Market by Sample Type
4.1 Europe Drug Testing Urine Samples Market by Country
4.2 Europe Drug Testing Oral Fluid Samples Market by Country
4.3 Europe Drug Testing Hair Samples Market by Country
4.4 Europe Drug Testing Other Samples Market by Country

Chapter 5. Europe Drug Testing Market by Product Type
5.1 Europe Consumables Drug Testing Market by Country
5.2 Europe Instruments Drug Testing Market by Country
5.3 Europe Rapid Testing Devices Drug Testing Market by Country
5.4 Europe Services Drug Testing Market by Country

Chapter 6. Europe Drug Testing Market by End-use
6.1 Europe Drug Testing Laboratories Drug Testing Market by Country
6.2 Europe Workplaces Drug Testing Market by Country
6.3 Europe Hospitals Drug Testing Market by Country
6.4 Europe Others Drug Testing Market by Country

Chapter 7. Europe Drug Testing Market by Country
7.1 Germany Drug Testing Market
7.1.1 Germany Drug Testing Market by Drug Type
7.1.2 Germany Drug Testing Market by Sample Type
7.1.3 Germany Drug Testing Market by Product Type
7.1.4 Germany Drug Testing Market by End-use
7.2 UK Drug Testing Market
7.2.1 UK Drug Testing Market by Drug Type
7.2.2 UK Drug Testing Market by Sample Type
7.2.3 UK Drug Testing Market by Product Type
7.2.4 UK Drug Testing Market by End-use
7.3 France Drug Testing Market
7.3.1 France Drug Testing Market by Drug Type
7.3.2 France Drug Testing Market by Sample Type
7.3.3 France Drug Testing Market by Product Type
7.3.4 France Drug Testing Market by End-use
7.4 Russia Drug Testing Market
7.4.1 Russia Drug Testing Market by Drug Type
7.4.2 Russia Drug Testing Market by Sample Type
7.4.3 Russia Drug Testing Market by Product Type
7.4.4 Russia Drug Testing Market by End-use
7.5 Spain Drug Testing Market
7.5.1 Spain Drug Testing Market by Drug Type
7.5.2 Spain Drug Testing Market by Sample Type
7.5.3 Spain Drug Testing Market by Product Type
7.5.4 Spain Drug Testing Market by End-use
7.6 Italy Drug Testing Market
7.6.1 Italy Drug Testing Market by Drug Type
7.6.2 Italy Drug Testing Market by Sample Type
7.6.3 Italy Drug Testing Market by Product Type
7.6.4 Italy Drug Testing Market by End-use
7.7 Rest of Europe Drug Testing Market
7.7.1 Rest of Europe Drug Testing Market by Drug Type
7.7.2 Rest of Europe Drug Testing Market by Sample Type
7.7.3 Rest of Europe Drug Testing Market by Product Type
7.7.4 Rest of Europe Drug Testing Market by End-use

Chapter 8. Company Profiles
8.1 Quest Diagnostics, Incorporated
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Recent strategies and developments:
8.1.2.1 Partnerships, Collaborations, and Agreements:
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 F. Hoffmann-La Roche Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Thermo Fisher Scientific, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 Siemens AG (Siemens Healthineers)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Agilent Technologies, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Bio-Rad laboratories, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.8 Dragerwerk AG & Co. KGaA
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 Quidel Corporation
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Trials & Approvals:
8.10. Omega Laboratories, Inc.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
8.10.2.2 Accreditation: